NYC-based immunotherapy startup Quentis comes to life with $48M – FierceBiotech
|
NYC-based immunotherapy startup Quentis comes to life with $48M
FierceBiotech NYC-based immunotherapy startup Quentis comes to life with $48M. by Amirah Al Idrus |. Feb 27, 2018 7:30am. Quentis is the second New York City-based biotech to launch within a week; it follows gut-brain biotech Kallyope, which debuted on Thursday … |
